Treatment - page 6

Pancreatic cancer is an aggressive tumor of the digestive system. One of the reasons for the low effectiveness of treatment for pancreatic tumors is the weak anti-tumor immune response. However, thanks to the groundbreaking discovery of dendritic cells by American immunologist Ralph Steinman – work that earned him the 2011 Nobel Prize in Medicine – we now have powerful new...

Dendritic cell-based immunotherapy is the administration of individually manufactured vaccines based on the genetic characteristics of a tumor in a particular person. Cancer treatment with dendritic cells is indicated even for those patients who have not responded to all other types of therapy. In Europe, vaccination is possible in any stage of cancer and has virtually no contraindications.

Breast cancer immunotherapy represents a groundbreaking advancement in oncology, encompassing various innovative approaches to cancer treatment. German clinics are at the forefront of implementing these advanced therapies, from immune checkpoint inhibitors to dendritic cell vaccines – the latter made possible by Ralph Steinman... 

Dendritic cell breast cancer treatment is a breakthrough immunotherapy approach that activates the patient's anti-cancer immunity through personalized vaccination. This innovative method improves treatment outcomes by 15-20% across different clinical situations: after tumor removal surgery, with lymph node involvement, in metastatic disease,...

A soft tissue sarcoma is a malignant, non-epithelial tumor. Such tumors may arise from muscles, adipose tissue, cartilage tissue, blood vessels, skin, etc. Sarcomas differ from cancer in that they do not grow from the epithelium. These are relatively rare tumors. They can develop in any part of the body. There are more than 50 histological types...

Glioblastoma is a malignant neoplasm that arises from glial cells of the brain. The tumor is heterogeneous and requires a differentiated therapeutic approach. When elaborating a treatment regimen, German oncologists take into account the molecular and genetic composition of the tumor and its location in relation to vital parts of the brain.

Standard therapy for glioblastoma includes surgical removal of the tumor in combination with chemotherapy or radiation therapy. With standard treatment, the average life expectancy after diagnosing the pathology is 15-17 months, and the 5-year survival rate does not exceed 3-5%. Supplementing the standard protocol with the dendritic...

Cancer is one of the most common causes of human deaths, along with cardiovascular pathologies. A complete cure or effective treatment has not been developed yet. Moreover, traditional therapy may not bring results to its advanced stage, so patients simply receive symptomatic treatment.